217 related articles for article (PubMed ID: 33299012)
1. BEX2 suppresses mitochondrial activity and is required for dormant cancer stem cell maintenance in intrahepatic cholangiocarcinoma.
Tamai K; Nakamura-Shima M; Shibuya-Takahashi R; Kanno SI; Yasui A; Mochizuki M; Iwai W; Wakui Y; Abue M; Yamamoto K; Miura K; Mizuma M; Unno M; Kawamura S; Sato I; Yasuda J; Yamaguchi K; Sugamura K; Satoh K
Sci Rep; 2020 Dec; 10(1):21592. PubMed ID: 33299012
[TBL] [Abstract][Full Text] [Related]
2. BEX2 is required for maintaining dormant cancer stem cell in hepatocellular carcinoma.
Fukushi D; Shibuya-Takahashi R; Mochizuki M; Fujimori H; Kogure T; Sugai T; Iwai W; Wakui Y; Abue M; Murakami K; Nakamura Y; Yasuda J; Yamaguchi K; Sugamura K; Shibata C; Katayose Y; Satoh K; Tamai K
Cancer Sci; 2021 Nov; 112(11):4580-4592. PubMed ID: 34424582
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a chemical compound that suppresses expression of BEX2, a dormant cancer stem cell-related protein.
Saijoh S; Nakamura-Shima M; Shibuya-Takahashi R; Ito R; Sugawara A; Yamazaki T; Imai T; Asada Y; Matsuura K; Iwai W; Wakui Y; Abue M; Kawamura S; Katayose Y; Fujimori H; Mochizuki M; Yasuda J; Yamaguchi K; Sugamura K; Satoh K; Katori Y; Tamai K
Biochem Biophys Res Commun; 2021 Jan; 537():132-139. PubMed ID: 33412384
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma.
Raggi C; Taddei ML; Sacco E; Navari N; Correnti M; Piombanti B; Pastore M; Campani C; Pranzini E; Iorio J; Lori G; Lottini T; Peano C; Cibella J; Lewinska M; Andersen JB; di Tommaso L; Viganò L; Di Maira G; Madiai S; Ramazzotti M; Orlandi I; Arcangeli A; Chiarugi P; Marra F
J Hepatol; 2021 Jun; 74(6):1373-1385. PubMed ID: 33484774
[TBL] [Abstract][Full Text] [Related]
5. Suppressive expression of CD274 increases tumorigenesis and cancer stem cell phenotypes in cholangiocarcinoma.
Tamai K; Nakamura M; Mizuma M; Mochizuki M; Yokoyama M; Endo H; Yamaguchi K; Nakagawa T; Shiina M; Unno M; Muramoto K; Sato I; Satoh K; Sugamura K; Tanaka N
Cancer Sci; 2014 Jun; 105(6):667-74. PubMed ID: 24673799
[TBL] [Abstract][Full Text] [Related]
6. Loss of ARID1A induces a stemness gene ALDH1A1 expression with histone acetylation in the malignant subtype of cholangiocarcinoma.
Yoshino J; Akiyama Y; Shimada S; Ogura T; Ogawa K; Ono H; Mitsunori Y; Ban D; Kudo A; Yamaoka S; Tanabe M; Tanaka S
Carcinogenesis; 2020 Jul; 41(6):734-742. PubMed ID: 31665232
[TBL] [Abstract][Full Text] [Related]
7. Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications.
Wu HJ; Chu PY
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450710
[TBL] [Abstract][Full Text] [Related]
8. Reciprocal Interaction of Cancer Stem Cells of Cholangiocarcinoma with Macrophage.
Wang X; Golino JL; Hawk NV; Xie C
Stem Cell Rev Rep; 2023 Aug; 19(6):2013-2023. PubMed ID: 37249733
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide screen identified let-7c/miR-99a/miR-125b regulating tumor progression and stem-like properties in cholangiocarcinoma.
Lin KY; Ye H; Han BW; Wang WT; Wei PP; He B; Li XJ; Chen YQ
Oncogene; 2016 Jun; 35(26):3376-86. PubMed ID: 26455324
[TBL] [Abstract][Full Text] [Related]
10. Multiple cellular origins and molecular evolution of intrahepatic cholangiocarcinoma.
Wei M; Lü L; Lin P; Chen Z; Quan Z; Tang Z
Cancer Lett; 2016 Sep; 379(2):253-61. PubMed ID: 26940139
[TBL] [Abstract][Full Text] [Related]
11. E3 ubiquitin ligase FBW7α inhibits cholangiocarcinoma cell proliferation by downregulating c-Myc and cyclin E.
Li M; Ouyang L; Zheng Z; Xiang D; Ti A; Li L; Dan Y; Yu C; Li W
Oncol Rep; 2017 Mar; 37(3):1627-1636. PubMed ID: 28184929
[TBL] [Abstract][Full Text] [Related]
12. FBXW7 suppresses epithelial-mesenchymal transition, stemness and metastatic potential of cholangiocarcinoma cells.
Yang H; Lu X; Liu Z; Chen L; Xu Y; Wang Y; Wei G; Chen Y
Oncotarget; 2015 Mar; 6(8):6310-25. PubMed ID: 25749036
[TBL] [Abstract][Full Text] [Related]
13. Profiles of cancer stem cell subpopulations in cholangiocarcinomas.
Cardinale V; Renzi A; Carpino G; Torrice A; Bragazzi MC; Giuliante F; DeRose AM; Fraveto A; Onori P; Napoletano C; Franchitto A; Cantafora A; Grazi G; Caporaso N; D'Argenio G; Alpini G; Reid LM; Gaudio E; Alvaro D
Am J Pathol; 2015 Jun; 185(6):1724-39. PubMed ID: 25892683
[TBL] [Abstract][Full Text] [Related]
14. Protein tyrosine phosphatase PTP4A1 promotes proliferation and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma via the PI3K/AKT pathway.
Liu LZ; He YZ; Dong PP; Ma LJ; Wang ZC; Liu XY; Duan M; Yang LX; Shi JY; Zhou J; Fan J; Gao Q; Wang XY
Oncotarget; 2016 Nov; 7(46):75210-75220. PubMed ID: 27655691
[TBL] [Abstract][Full Text] [Related]
15. Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis.
Armartmuntree N; Murata M; Techasen A; Yongvanit P; Loilome W; Namwat N; Pairojkul C; Sakonsinsiri C; Pinlaor S; Thanan R
Redox Biol; 2018 Apr; 14():637-644. PubMed ID: 29169115
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of tumorigenic extrahepatic cholangiocarcinoma cells with stem cell-like properties.
Wang M; Xiao J; Shen M; Yahong Y; Tian R; Zhu F; Jiang J; Du Z; Hu J; Liu W; Qin R
Int J Cancer; 2011 Jan; 128(1):72-81. PubMed ID: 20232394
[TBL] [Abstract][Full Text] [Related]
17. Aberrant activation of Notch signaling in extrahepatic cholangiocarcinoma: clinicopathological features and therapeutic potential for cancer stem cell-like properties.
Aoki S; Mizuma M; Takahashi Y; Haji Y; Okada R; Abe T; Karasawa H; Tamai K; Okada T; Morikawa T; Hayashi H; Nakagawa K; Motoi F; Naitoh T; Katayose Y; Unno M
BMC Cancer; 2016 Nov; 16(1):854. PubMed ID: 27821106
[TBL] [Abstract][Full Text] [Related]
18. The SIRT2/cMYC Pathway Inhibits Peroxidation-Related Apoptosis In Cholangiocarcinoma Through Metabolic Reprogramming.
Xu L; Wang L; Zhou L; Dorfman RG; Pan Y; Tang D; Wang Y; Yin Y; Jiang C; Zou X; Wu J; Zhang M
Neoplasia; 2019 May; 21(5):429-441. PubMed ID: 30933885
[TBL] [Abstract][Full Text] [Related]
19. Antisense RhoC gene suppresses proliferation and invasion capacity of human QBC939 cholangiocarcinoma cells.
Shi Z; Chen ML; He QL; Zeng JH
Hepatobiliary Pancreat Dis Int; 2007 Oct; 6(5):516-20. PubMed ID: 17897917
[TBL] [Abstract][Full Text] [Related]
20. Alpha-fetoprotein producing cells act as cancer progenitor cells in human cholangiocarcinoma.
Ishii T; Yasuchika K; Suemori H; Nakatsuji N; Ikai I; Uemoto S
Cancer Lett; 2010 Aug; 294(1):25-34. PubMed ID: 20149523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
